¼¼°èÀÇ ¼±Ãµ¼º ½ÉÁúȯ¿ë µð¹ÙÀ̽º ½ÃÀå º¸°í¼­(2025³â)
Congenital Heart Defect Devices Global Market Report 2025
»óǰÄÚµå : 1703202
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,387,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,232,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,077,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼±Ãµ¼º ½ÉÀåÁúȯ¿ë ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 7.2%·Î 41¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ÀÓ»ó½ÃÇè Áõ°¡, ³ëÀÎ Àα¸ÀÇ ±ÞÁõ, ¼±Ãµ¼º ½ÉÀ庴 À¯º´·ü Áõ°¡, Á¤ºÎ Áö¿ø ¹× ÀÚ±Ý Áö¿ø Áõ°¡, Àü¹® ÀÇ·á ¼¾ÅÍ Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, µðÁöÅÐ Çコ ±â¼ú, ¸ÂÃãÇü ÀÇ·á, 3D ÇÁ¸°ÆÃ ±â¼ú, ¿þ¾î·¯ºí ±â±â µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

¼±Ãµ¼º ½ÉÀ庴 Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ÃÖ¼Ò Ä§½À ¼ö¼ú Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àúħ½À ¼ö¼úÀº ¿Ü»óÀ» ÃÖ¼ÒÈ­Çϰí ȸº¹À» °³¼±Çϱâ À§ÇØ Æ¯¼ö Åø¿Í ±â¼úÀ» »ç¿ëÇÏ¿© ÀÛÀº Àý°³³ª ÀÚ¿¬Àû ½Åü ±¸¸ÛÀ» ÅëÇØ ¼ö¼úÀ» ½ÃÇàÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú Áõ°¡ ¿äÀÎÀ¸·Î´Â ±â¼ú ¹ßÀü, ÃÖ¼Ò Ä§½ÀÀû Ä¡·á¹ý¿¡ ´ëÇÑ È¯ÀÚ ¼±È£µµ, ¼ö¼ú ±â¼ú Çâ»ó, ȸº¹ ½Ã°£ ¹× ÇÕº´Áõ °¨¼Ò·Î ÀÎÇÑ ÀÌÁ¡ µîÀÌ ÀÖ½À´Ï´Ù. ¼±Ãµ¼º ½ÉÀåÁúȯ¿ë Àåºñ´Â ´õ ÀÛÀº Àý°³¿Í Ä«Å×Å͸¦ ÀÌ¿ëÇÑ Á¢±ÙÀ» ÅëÇØ ½ÉÀå ÀÌ»óÀ» Áø´Ü, Ä¡·á, °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ½Ã¼ú¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(ASPS)¿¡ µû¸£¸é 2022³â ¹Ì±¹¿¡¼­ ¹Ì¿ë ¸ñÀûÀ¸·Î ½ÃÇàµÈ ÃÖ¼Òħ½À ¼ö¼úÀº 2,367¸¸ 2,269°ÇÀ¸·Î Àü³â ´ëºñ 7% Áõ°¡Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ÃÖ¼Òħ½À¼ö¼ú Áõ°¡´Â °á°úÀûÀ¸·Î ¼±Ãµ¼º ½ÉÀåÁúȯ ±â±â ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¼±Ãµ¼º ½ÉÀåÁúȯ(CHD) ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ÀÌ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ü°áÇÏ´Â »ç·Ê°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÆÄÆ®³Ê½ÊÀº ÀÚ¿ø°ú Àü¹®Áö½ÄÀ» °áÇÕÇϰí, ¿¬±¸°³¹ß ³ë·ÂÀ» °­È­Çϰí, ½ÃÀå °³¹ßÀ» È®´ëÇϸç, »ó¾÷È­ °úÁ¤À» °¡¼ÓÈ­ÇÔÀ¸·Î½á CHD ±â±â ºÐ¾ßÀÇ ±â¾÷À» µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çù·Â °ü°è´Â Çõ½ÅÀ» ÃËÁøÇÏ°í »ê¾÷ ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù ÀεµÀÇ Á¦Á¶ ȸ»çÀÎ SMT(Sahajanand Medical Technologies Pvt Ltd)´Â ¼øÈ¯±â ºÐ¾ßÀÇ È¯ÀÚ Ä¡·á¸¦ °³¼±Çϱâ À§ÇØ ÀεµÀÇ MedTech ±â¾÷ÀÎ HeartX¿Í ÆÄÆ®³Ê½ÊÀ» ü°áÇß½À´Ï´Ù. À̹ø Á¦ÈÞ¸¦ ÅëÇØ »çÇÏÀÜµå ¸ÞµðÄà Å×Å©³î·¯Áö½º(SMT)´Â JOVE VB ½ºÅÙÆ® µî HeartXÀÇ ÃÖ÷´Ü ¼Ö·ç¼ÇÀ» µµÀÔÇÏ¿© CHD ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¿¹Á¤ÀÔ´Ï´Ù. À̹ø Á¦ÈÞ¸¦ ÅëÇØ SMT´Â Ä¡·á È¿°ú¸¦ ³ôÀ̰í, ½Ã¼úÀ» °£¼ÒÈ­Çϸç, ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϴ ÷´Ü CHD ±â±â¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.91 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congenital Heart Defect Devices Growth Analysis And Strategic Analysis Framework

6. Congenital Heart Defect Devices Market Segmentation

7. Congenital Heart Defect Devices Market Regional And Country Analysis

8. Asia-Pacific Congenital Heart Defect Devices Market

9. China Congenital Heart Defect Devices Market

10. India Congenital Heart Defect Devices Market

11. Japan Congenital Heart Defect Devices Market

12. Australia Congenital Heart Defect Devices Market

13. Indonesia Congenital Heart Defect Devices Market

14. South Korea Congenital Heart Defect Devices Market

15. Western Europe Congenital Heart Defect Devices Market

16. UK Congenital Heart Defect Devices Market

17. Germany Congenital Heart Defect Devices Market

18. France Congenital Heart Defect Devices Market

19. Italy Congenital Heart Defect Devices Market

20. Spain Congenital Heart Defect Devices Market

21. Eastern Europe Congenital Heart Defect Devices Market

22. Russia Congenital Heart Defect Devices Market

23. North America Congenital Heart Defect Devices Market

24. USA Congenital Heart Defect Devices Market

25. Canada Congenital Heart Defect Devices Market

26. South America Congenital Heart Defect Devices Market

27. Brazil Congenital Heart Defect Devices Market

28. Middle East Congenital Heart Defect Devices Market

29. Africa Congenital Heart Defect Devices Market

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

34. Recent Developments In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â